References
- HenselerTChristophersEDisease concomitance in psoriasisJ Am Acad Dermatol19953269829867751469
- KruegerGGPappKAStoughDBA randomized, double-blind, placebo controlled phase III study evaluating efficacy and tolerability of 2 courses of alefacept in patients with chronic plaque psoriasisJ Am Acad Dermatol200247682183312451365
- MeasePJGoffeBSMetzJEtanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trialLancet2000356922738539010972371
- ShiraiKObesity as the core of the metabolic syndrome and the management of coronary heart diseaseCurr Med Res Opin200420329530415025838
- NaldiLChatenoudLLinderDCigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case–control studyJ Invest Dermatol20051251616715982303
- NeimannALShinDBWangXPrevalence of cardiovascular risk factors in patients with psoriasisJ Am Acad Dermatol200655582983517052489
- HerronMDHinckleyBHoffmanMSImpact of obesity and smoking on psoriasis presentation and managementArch Dermatol2005141121527153416365253
- EckelRHGrundySMZimmetPZThe metabolic syndromeLancet200536594681415142815836891
- GelfandJMNeimannALShinDBRisk of myocardial infarction in patients with psoriasisJAMA2006296141735174117032986
- SommerDMJenischSSuchanMIncreased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArch Dermatol Res2006298732132817021763
- SattarNMcCareyDWCapellHMcInnesIBExplaining how ‘high-grade’ systemic inflammation accelerates vascular risk in rheumatoid arthritisCirculation2003108242957296314676136
- RontiTLupattelliGMannarinoEThe endocrine function of adipose tissue: an updateClin Endocrinol (Oxf)200664435526516584505
- PischonTGirmanCJHotamisligilGSPlasma adiponectin levels and risk of myocardial infarction in menJAMA2004291141730173715082700
- LudwigRJHerzogCRostockAPsoriasis: a possible risk factor for development of coronary artery calcificationBr J Dermatol2007156227127617223866
- CoppackSWPro-inflammatory cytokines and adipose tissueProc Nutr Soc200160334935611681809
- PietschJBatraAStrohTToll-like receptor expression and response to specific stimulation in adipocytes and preadipocytesAnn N Y Acad Sci2006107240740917057223
- RajalaMWSchererPEMini review: the adipocyte – at the crossroads of energy homeostasis, inflammation and atherosclerosisEndocrinology200314493765377312933646
- LeinoMMustonenAMattilaKKouluLTuominenRPerceived impact of psoriasis on leisure-time activitiesEur J Dermatol201424222422824704621
- FeldmanSRMalakoutiMKooJYSocial impact of the burden of psoriasis: effects on patients and practiceDermatol Online J2014208 pii: 13030/qt48r4w8h2
- BernsteinLEBerryJKimSEffects of etanercept in patients with the metabolic syndromeArch Intern Med2006166890290816636217
- ProdanovichSMaFTaylorJRMethotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritisJ Am Acad Dermatol200552226226715692471
- GrundySMCleemanJIDanielsSRDiagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific StatementCirculation2005112172735375216157765
- EckelRHAlbertiKGGrundySMZimmetPZThe metabolic syndromeLancet2010375971018118320109902
- Rocha-PereiraPSantos-SilvaARebeloIDyslipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular diseaseClin Chim Acta20013031–2333911163020